A study with db/db mice and the NLRP3 selective inhibitor MCC950 also indicated that NLRP3 and pro-inflammatory cytokines contributed to vascular dysfunction in T2DM [28]. Here, NLRP3 is linked to type 2 diabetes mellitus.